MedTrace Logo

Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus

NCT07111325 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-08-08

No results posted yet for this study

Summary

Evaluate the safety and preliminary efficacy of human induced pluripotent stem cell-derived extracellular vesicle (iEV) injection in the treatment of lateral epicondylitis of the humerus.

Conditions

  • Lateral Epicondylitis

Interventions

BIOLOGICAL

iEV

induced pluripotent stem cell-derived extracellular vesicles

BIOLOGICAL

PRP

PRP injection

OTHER

immobilization

immobilization

Sponsors & Collaborators

  • Shanghai 6th People's Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2025-12-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111325 on ClinicalTrials.gov